Last news
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors

Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors

...

MARRIOTT INTERNATIONAL CELEBRATES 1,000 HOTELS IN ASIA PACIFIC

MARRIOTT INTERNATIONAL CELEBRATES 1,000 HOTELS IN ASIA PACIFIC

...

Manhattan Associates Launches Landmark Unified Commerce Benchmark for Specialty Retail

Manhattan Associates Launches Landmark Unified Commerce Benchmark for Specialty Retail

...

Zenarate Applauded by Frost & Sullivan for Reducing Costs and Improving Customer Experience in Contact Center to Deliver Value

Zenarate Applauded by Frost & Sullivan for Reducing Costs and Improving Customer Experience in Contact Center to Deliver Value

...

Dingdong Files Its Annual Report on Form 20-F

Dingdong Files Its Annual Report on Form 20-F

...

ALLPOWERS' Cutting-Edge and Green-Friendly R3500 Smart Home Energy Kit to Launch on Kickstarter

ALLPOWERS' Cutting-Edge and Green-Friendly R3500 Smart Home Energy Kit to Launch on Kickstarter

...

Rokid leads the charge in AR tech innovation with the new Rokid Max AR glasses set

Rokid leads the charge in AR tech innovation with the new Rokid Max AR glasses set

...

Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma

Ascentage Pharma Announces 2022 Annual Results Including Strong Sales of Olverembatinib and Steady Progress in Transition Towards Biopharma

...

menu
menu